Dyslipidaemia (Q28205109)

The proving of the lipid hypothesis

Europe PubMed Central

title

Dyslipidaemia (English)

0 references

1 reference

Paul Durrington

1

0 references

language of work or name

English

0 references

publication date

30 August 2003

0 references

published in

The Lancet

0 references

volume

362

0 references

page(s)

717-31

0 references

issue

9385

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Rigorous detection and vigorous treatment of familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Type II hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Therapeutic effects of LDL apheresis in the prevention of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

[Allogenic liver transplantation: a form of "gene therapy" in metabolic diseases. Munich results and a review]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Coronary heart disease — The global picture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Epidemiology of coronary heart disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

An updated coronary risk profile. A statement for health professionals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Blood lipids in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Dietary therapy of hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Coronary heart disease in south Asians overseas: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The thrifty genotype in non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Early initiation of treatment with statins in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Early statin initiation and outcomes in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Family study of serum lipids and lipoproteins in coronary heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Defects of lipoprotein metabolism in familial combined hyperlipidaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Cholesteryl ester transfer protein, high density lipoprotein and arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Triglycerides are more important in atherosclerosis than epidemiology has suggested

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Paraoxonase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Bezafibrate in men with lower extremity arterial disease: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Severe hypertriglyceridemia associated with pancytopenia and lipoprotein lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Prevention of recurrent pancreatitis in familial lipoprotein lipase deficiency with high-dose antioxidant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Coronary heart disease mortality is actually low in diabetic Japanese by direct comparison with the Joslin cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Transvascular low-density lipoprotein transport in patients with diabetes mellitus (type 2): a noninvasive in vivo isotope technique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Hypertension, serum insulin, obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The role of insulin resistance and hyperinsulinemia in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Cardiovascular prevention before admission reduces mortality following acute myocardial infarction in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Lipoprotein deficiency disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

ATP-binding cassette transporter A1 and cholesterol trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

Indications for cholesterol-lowering medication: comparison of risk-assessment methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914234-1

7 January 2021

10.1016/S0140-6736(03)14234-1

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

412105

412105

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference